搜尋





搜尋





市場行情
/
股票
/
spro
/

Spero Therapeutics Inc

SPRO

添加自選

1.195USD

+0.015+1.27%

收盤 07-28 16:00（美東）報價延遲15分鐘

69.18M總市值

4.30本益比TTM

Spero Therapeutics Inc

1.195

+0.015+1.27%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

SPRO 利潤表

您可以在這裡找到Spero Therapeutics Inc的年度或季度收入報告，以深入了解Spero Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

營業總收入

-95.61%258.00K

174.51%41.30M

-59.60%5.44M

39.15%14.19M

-36.61%5.87M

-79.54%15.04M

-47.12%13.47M

275.44%10.20M

347.90%9.27M

54.98%73.52M

1169.84%25.47M

36.28%2.72M

0.00%2.07M

1628.90%47.44M

-34.53%2.01M

-61.29%1.99M

-71.66%2.07M

43.89%2.74M

-23.30%3.06M

198.09%5.15M

329.16%7.30M

-47.47%1.91M

-13.96%4.00M

-19.90%1.73M

-77.96%1.70M

114.54%3.63M

605.62%4.64M

365.66%2.16M

569.38%7.72M

70.39%1.69M

10.22%658.00K

85.94%463.00K

723.57%1.15M

196.42%993.00K

--597.00K

--249.00K

--140.00K

--335.00K

--0.00

營業收入

-95.61%258.00K

174.51%41.30M

-59.60%5.44M

39.15%14.19M

-36.61%5.87M

-79.54%15.04M

-47.12%13.47M

275.44%10.20M

347.90%9.27M

54.98%73.52M

1169.84%25.47M

36.28%2.72M

0.00%2.07M

1628.90%47.44M

-34.53%2.01M

-61.29%1.99M

-71.66%2.07M

43.89%2.74M

-23.30%3.06M

198.09%5.15M

329.16%7.30M

-47.47%1.91M

-13.96%4.00M

-19.90%1.73M

-77.96%1.70M

114.54%3.63M

605.62%4.64M

365.66%2.16M

569.38%7.72M

70.39%1.69M

10.22%658.00K

85.94%463.00K

723.57%1.15M

196.42%993.00K

--597.00K

--249.00K

--140.00K

--335.00K

--0.00

營業費用

-61.84%7.80M

-72.44%9.89M

-60.17%12.77M

-43.43%16.55M

-12.13%20.43M

56.12%35.89M

45.07%32.06M

87.48%29.26M

42.67%23.25M

6.51%22.99M

57.95%22.10M

-3.81%15.61M

-49.51%16.30M

-28.64%21.58M

-45.32%13.99M

-31.52%16.22M

20.87%32.28M

46.09%30.25M

11.18%25.59M

17.26%23.69M

8.89%26.70M

-29.85%20.70M

1.71%23.02M

27.80%20.20M

82.81%24.52M

131.00%29.51M

95.19%22.63M

51.50%15.81M

12.07%13.41M

-14.79%12.78M

9.75%11.59M

0.19%10.43M

54.66%11.97M

63.95%14.99M

33.47%10.56M

--10.41M

--7.74M

--9.14M

--7.91M

研發費用

-78.62%2.91M

-80.61%5.59M

-68.00%8.60M

-55.02%10.67M

-21.50%13.61M

74.16%28.84M

63.87%26.86M

149.47%23.73M

93.03%17.33M

9.73%16.56M

122.73%16.39M

16.36%9.51M

-47.09%8.98M

-12.40%15.09M

-49.02%7.36M

-43.48%8.17M

-7.79%16.97M

30.44%17.23M

-18.47%14.44M

-7.63%14.46M

-9.94%18.40M

-48.67%13.21M

-4.27%17.71M

30.18%15.66M

114.53%20.44M

181.89%25.73M

118.64%18.50M

63.09%12.03M

6.73%9.53M

-27.00%9.13M

22.42%8.46M

-1.11%7.37M

48.77%8.93M

80.50%12.50M

15.07%6.91M

--7.46M

--6.00M

--6.93M

--6.00M

折舊攤銷及損耗

----

-100.00%0.00

-98.15%2.00K

-100.00%0.00

-44.96%71.00K

-57.98%108.00K

-63.27%108.00K

-40.21%113.00K

-32.46%129.00K

73.65%257.00K

98.65%294.00K

18.87%189.00K

0.00%191.00K

-22.51%148.00K

-22.11%148.00K

-15.87%159.00K

--191.00K

-60.94%191.00K

1.06%190.00K

2.72%189.00K

----

503.70%489.00K

100.00%188.00K

93.68%184.00K

40.40%139.00K

-13.83%81.00K

13.25%94.00K

9.20%95.00K

16.47%99.00K

27.03%94.00K

--83.00K

--87.00K

--85.00K

--74.00K

營業利潤

48.21%-7.54M

250.64%31.41M

60.58%-7.33M

87.61%-2.36M

-4.11%-14.56M

-141.26%-20.85M

-651.39%-18.59M

-47.87%-19.06M

1.72%-13.98M

95.43%50.53M

128.13%3.37M

9.42%-12.89M

52.90%-14.23M

194.02%25.86M

46.79%-11.99M

23.25%-14.23M

-55.68%-30.21M

-46.32%-27.50M

-18.42%-22.52M

-0.36%-18.54M

14.98%-19.40M

27.38%-18.80M

-5.75%-19.02M

-35.34%-18.48M

-300.65%-22.82M

-133.52%-25.88M

-64.47%-17.98M

-36.92%-13.65M

47.34%-5.70M

20.83%-11.08M

-9.72%-10.94M

1.91%-9.97M

-42.33%-10.82M

-58.91%-14.00M

-25.93%-9.97M

---10.16M

---7.60M

---8.81M

---7.91M

淨非營業利息收入（費用）

利息收入

-61.11%336.00K

-63.42%376.00K

-54.99%532.00K

-38.23%740.00K

-34.89%864.00K

-1.44%1.03M

24.42%1.18M

22.00%1.20M

37.80%1.33M

45.87%1.04M

356.73%950.00K

784.68%982.00K

1237.50%963.00K

840.79%715.00K

131.11%208.00K

35.37%111.00K

-26.53%72.00K

55.10%76.00K

210.34%90.00K

-4.65%82.00K

-58.65%98.00K

-96.31%49.00K

--29.00K

--86.00K

--237.00K

--1.33M

----

利息費用

----

--0.00

-100.00%0.00

--0.00

--117.00K

--2.49M

--1.94M

----

特殊收入（費用）

100.00%0.00

---587.00K

---83.00K

---175.00K

---877.00K

100.00%0.00

----

-100.00%0.00

-4311.11%-5.31M

100.00%0.00

1.96%208.00K

--126.00K

---14.44M

---193.00K

--204.00K

----

-100.00%0.00

----

--223.00K

----

100.00%0.00

-100.00%0.00

-100.97%-6.00K

50.00%-2.00K

--350.00K

--1.20M

--617.00K

---4.00K

其他非經營性收入（費用）

-200.00%-1.00K

-100.00%0.00

107.69%2.00K

300.00%4.00K

107.14%1.00K

3200.00%99.00K

-160.00%-26.00K

116.67%1.00K

-600.00%-14.00K

133.33%3.00K

56.52%-10.00K

40.00%-6.00K

84.62%-2.00K

88.46%-9.00K

73.56%-23.00K

91.07%-10.00K

88.98%-13.00K

-148.15%-78.00K

-258.18%-87.00K

-112.60%-112.00K

82.49%-118.00K

124.77%162.00K

-79.48%55.00K

77.09%889.00K

-208.01%-674.00K

-234.85%-654.00K

-43.22%268.00K

3246.67%502.00K

262.79%624.00K

251.45%485.00K

280.65%472.00K

-71.15%15.00K

1663.64%172.00K

3550.00%138.00K

--124.00K

--52.00K

---11.00K

---4.00K

--0.00

稅前利潤

48.05%-7.20M

254.29%31.78M

57.66%-7.38M

90.48%-1.70M

-9.45%-13.87M

-139.94%-20.60M

-1654.23%-17.44M

-49.92%-17.86M

4.50%-12.67M

92.66%51.58M

91.49%-994.00K

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

16.49%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-358.56%-23.26M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

23.57%-10.60M

-6.29%-10.46M

-1.98%-9.96M

-66.03%-10.64M

-69.18%-13.87M

-24.32%-9.84M

---9.76M

---6.41M

---8.20M

---7.92M

所得稅

----

-10.00%261.00K

100.00%0.00

----

-25.06%290.00K

-113.12%-290.00K

----

--387.00K

--2.21M

----

--0.00

----

--0.00

----

除稅後利潤

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

16.49%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-358.56%-23.26M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

23.57%-10.60M

-6.29%-10.46M

-1.98%-9.96M

-66.03%-10.64M

-69.18%-13.87M

-24.32%-9.84M

---9.76M

---6.41M

---8.20M

---7.92M

持續經營利潤

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

16.49%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-358.56%-23.26M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

23.57%-10.60M

-6.29%-10.46M

-1.98%-9.96M

-66.03%-10.64M

-69.18%-13.87M

-24.32%-9.84M

---9.76M

---6.41M

---8.20M

---7.92M

反常淨利潤

----

--0.00

----

--0.00

----

歸屬少數股東的淨利潤

----

100.00%0.00

99.39%-6.00K

99.50%-8.00K

---594.00K

---535.00K

---986.00K

---1.60M

歸属于母公司的淨利潤

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

18.41%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-369.38%-23.81M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

28.24%-10.60M

13.36%-10.46M

17.86%-9.96M

-49.28%-10.64M

-77.25%-14.77M

-62.97%-12.08M

---12.12M

---7.13M

---8.33M

---7.41M

優先股派息

----

--0.00

----

--0.00

--549.00K

----

-100.00%0.00

----

-9.26%833.00K

124.02%2.05M

--2.02M

--1.24M

--918.00K

--916.00K

歸屬普通股東的淨利潤

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

18.41%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-369.38%-23.81M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

28.24%-10.60M

13.36%-10.46M

17.86%-9.96M

-49.28%-10.64M

-77.25%-14.77M

-62.97%-12.08M

---12.12M

---7.13M

---8.33M

---7.41M

基本每股收益

49.78%-0.13

245.72%0.56

58.60%-0.13

90.83%-0.03

-5.79%-0.25

-139.65%-0.38

-421.05%-0.32

-46.08%-0.33

6.28%-0.24

76.19%0.97

81.31%-0.06

73.94%-0.23

74.92%-0.25

160.61%0.55

53.58%-0.33

-38.97%-0.87

-52.47%-1.01

-33.37%-0.90

18.82%-0.70

26.21%-0.63

45.75%-0.66

48.26%-0.68

9.08%-0.86

-13.96%-0.85

-313.31%-1.22

-119.58%-1.31

-58.55%-0.95

-7.48%-0.74

60.24%-0.29

41.93%-0.60

31.08%-0.60

20.60%-0.69

-44.38%-0.74

-71.43%-1.03

-62.97%-0.87

---0.87

---0.51

---0.60

---0.53

稀釋每股收益

49.78%-0.13

220.05%0.46

58.60%-0.13

90.83%-0.03

-5.79%-0.25

-140.51%-0.38

-421.05%-0.32

-46.08%-0.33

6.28%-0.24

72.48%0.95

81.31%-0.06

73.94%-0.23

74.92%-0.25

160.61%0.55

53.58%-0.33

-38.97%-0.87

-52.47%-1.01

-33.37%-0.90

18.82%-0.70

26.21%-0.63

45.75%-0.66

48.26%-0.68

9.08%-0.86

-13.96%-0.85

-313.31%-1.22

-119.58%-1.31

-58.55%-0.95

-7.48%-0.74

60.24%-0.29

41.93%-0.60

31.08%-0.60

20.60%-0.69

-44.38%-0.74

-71.43%-1.03

-62.97%-0.87

---0.87

---0.51

---0.60

---0.53

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Spero Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 SPRO 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Spero Therapeutics Inc 財年末的營收是多少？



Spero Therapeutics Inc 2025 財年營收為 66.80M，高於上一財年的 47.98M。

Spero Therapeutics Inc 最近一個季度的營收是多少？



Spero Therapeutics Inc 最近一個季度的營收為 258.00K，同比增長 -95.61%。

Spero Therapeutics Inc 全年的淨利潤是多少？



Spero Therapeutics Inc 2025 財年淨利潤為 8.57M。

Spero Therapeutics Inc 上一季度的淨利潤是多少？



Spero Therapeutics Inc 最近一個季度的淨利潤為 -7.20M。

Spero Therapeutics Inc 年度營業利潤是多少？



Spero Therapeutics Inc 2025 財年的營業利潤為 7.16M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。